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Abstract 
Opioid use disorder (OUD) is a mental health condition that has high personal, societal, 
and emotional costs. Opioid use disorder, misuse, and abuse is a national epidemic. Many 
factors have contributed to the increased use of opioids and OUD. One such factor is the 
heightened emphasis on pain management in the medical community, one that that began 
nearly two decades ago. This has led to increased prescribing of opioid-based medication 
for chronic pain patients. This contributed in part to the development of OUD in many 
individuals who became addicted to opioids. For this reason, current guidelines 
discourage the use of opioid-based pain medication for chronic pain under most 
conditions. The purpose of this study is to evaluate the relationship between physician 
characteristics (i.e. length of time since graduation, physician specialty), and opioid 
knowledge and opioid/non-opioid treatment recommendations for the treatment of 
chronic pain. It was hypothesized that, in light of the heightened emphasis on opioid use 
and pain management using non-opioid alternatives, physicians who graduated more 
recently would have greater opioid knowledge and will recommend more alternative 
chronic pain treatment strategies. The present study included 49 physicians who were 
contacted through social media and email. Responding physicians were asked to 
complete multiple measures, following a brief screening for inclusion. They were then 
asked to read a brief vignette involving a patient experiencing chronic pain and to select 
from a list of all treatment recommendations that they would endorse. Finally, they were 
asked to complete a brief opioid knowledge survey developed for this study and a 
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demographic questionnaire. Results revealed no significant association between year of 
graduation, physician specialty, age, race, or biological sex on opioid knowledge or use 
of non-opioid alternative treatments. Future research using a larger sample size, with 
different specialties, or looking at differences between medical degree (allopathic vs. 
osteopathic) may yield more significant findings. 
VI 
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Chapter 1: Introduction 
Statement of the Problem 
Addiction and substance use were responsible for approximately 29,000 alcohol 
and 46,4 71 drug related deaths in 2013, meaning that the death rate for both illicit and 
legal substances rose from 13.8% to 14.6% between 2012 and 2013 (Xu, Murphy, 
Kochanek, & Bastian, 2016). The Center for Disease Control notes in a review on 
prescription drug overdoses that there were 27,000 unintentional overdoses in 2006 
(Center for Disease Control, 2012). In 2016, there were 63,632 overdose death, which 
continued to rise in 2017 to 70,237 deaths, with 67.8% of them involving opioids (Scholl, 
Seth, Kaiisa, Wilson & Baldwin, 2019). In 2014, approximately 21.5 million Americans 
suffered from substance use disorders (SUDs ), and this excludes those 12 and under who 
may also suffer with SUDs (Substance Abuse and Mental Health Services administration; 
SAMHSA, 2016a). SUDs can have a major impact on an individual's health, finances, 
and interpersonal experiences (van Boeke!, Browers, van Weeghel, & Garreston, 2013; 
National Institute on Drug Abuse (NIDA), 2015; Agabio, Campesi, Pisanu, Gessa & 
Franconi, 2016; Muller, Skurtveit, & Clausen, 2016). Societal costs related to SUDs are 
high as well (NIDA, 2016). In the United States in 2015, 3.5 million people received 
substance use treatment, accounting for 1.4% of all individuals in the population 18 or 
older, although 8.4% of the 18 and older population in the U.S. needed treatment 
(SAMHSA, 2016a). 
Currently there are psychosocial and pharmacological interventions available to 
address SUDs; however, individuals with substance use disorders face stigma from their 
communities, society, and medical and mental health professionals (Rao et al., 2009; van 
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Boeke! et al., 2013; Avery, Zerbo, & Ross, 2016; Mundon, Anderson, & Najavits, 2016). 
Van Boeke! et al. (2013) conducted a systematic review of healthcare delivery to those 
with substance use disorders, using 28 studies. The authors aimed to assess health care 
professionals' attitudes towards substance use in W estem countries, and to evaluate the 
cause and impact of these attitudes. Findings indicated that when health professionals 
exhibit negative attitudes towards those with substance use disorders, there is more likely 
to be a negative impact on communication (e.g. avoidance of a patient, limited time spent 
working with the patient), reduced treatment-seeking on behalf of patients, and a negative 
impact on clinician empathy and engagement. Negative attitudes towards substance use 
were also found to be associated with a higher likelihood that physical complaints will be 
attributed to substance use, rather than other causes (van Boeke! et al., 2013). Negative 
attitudes in this study were associated with beliefs that individuals with substance use 
disorders are manipulative, aggressive or violent and poorly motivated, leading to lower 
regard and motivation to treat on behalf of clinicians. Additionally, low regard for, or 
dissatisfaction with, substance use clients can lead to suboptimal care or perceived 
clinician hostility in treatment, thus negatively impacting referrals for care, SUDs 
diagnosis, and/or patient self-perception (Meltzer et al., 2013). 
Medical professionals are not alone in stigmatizing individuals with substance use 
issues. In one study of 155 clinical psychology trainees, substance use was more likely to 
be attributed to limited will-power and less likely to be attributed to a chemical 
imbalance, when compared with beliefs about major depressive disorder (Mundon, 
Anderson, & Najavits, 2015). Alternatively, stressful life circumstances, family 
upbringing and genetics were endorsed as the leading causes of substance use disorders 
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when considered alone. Furthermore, negative judgements towards individuals with 
substance use disorders actually lessened over the course of training (Mund on et al., 
2015). 
Increased interaction with those who experience SUDs is associated with a 
reduction in stigmatizing beliefs (Meltzer, 2013; Mundon et al., 2015). Addiction and 
abuse of illicit drugs has become a public health crisis, most notably in regard to 
prescription opioid use (Wright et al., 2014; Compton, Boyle, & Wargo, 2015; Maxwell, 
2016). In 2017, there were 70,237 drug overdose deaths in the United States; 67.8% of 
these deaths involved opioids, reflecting a 12% increase from 2016 (Scholl et al., 2019). 
Prior to this increase, the surgeon general announced that it was necessary to address 
opioid addiction in a way that reflects the high degree of a public health crisis that it is, 
and that medical professionals play an important role in addressing this issue (United 
States Department of Health and Human Services; USDHHS, 2016) 
3 
As prescribers, doctors truly are on the front line of addressing the opioid 
epidemic. Physicians prescribe opioids for a variety of health conditions to assist in pain 
management. They are faced with the responsibility of helping patients manage pain 
through healthy and safe treatments. Although opioids may be clinically indicated at 
times, emerging research indicates that, in many instances, opioid analgesics are causing 
more harm than good due to the addictive potential and questionable efficacy of these 
prescriptions over time (Compton et al., 2015), as well as the substantial health risks that 
older adults may be more susceptible to (Graf, 2010; Solomon et al., 2010). The 
prescription of addictive medicines is particularly concerning, given that medical 
professionals are ill equipped to manage the challenge of substance use disorders in 
PHYSICIANS' USE OF PAIN MANAGEMENT STRATEGIES 4 
medical settings, despite the frequency in which physicians are presented with drug-
related issues, such as substance dependence (Kennedy-Hendricks et al., 2016; Kotz, 
2016; Ram & Chisolm, 2016). The literature indicates a number of factors associated 
with difficulty in managing substance use disorders in medical settings, including: limited 
knowledge of appropriate referral sources and interventions, negative perceptions of 
substance users, lack of time, and limited training in substance use interventions (Kotz, 
2014; Meltzer et al., 2013; Ram & Chisolm, 2016; Satterfield et al., 2012). Studies 
suggest that these factors lead to inadequate care and identification of substance use 
issues (Neufeld et al., 2012; van Boeke! et al., 2013 Avery et al., 2016; Kennedy-
Hendricks et al., 2016; Kotz, 2014; Ram & Chisolm, 2016). 
Prevention may be one of the best methods for addressing this epidemic 
(USDHHS, 2016). One way in which the medical community can contribute to 
prevention efforts is to reduce opioid-based medication management for pain. Chronic 
pain is a condition that affects 11.2% of adults, and another 10.3% report experiencing "a 
lot" of pain (Nahin, 2012). Treatments for chronic pain range from cognitive behavioral 
therapy (CBT) and lifestyle changes to medication management, including opioid 
prescriptions (Gladkowski, Medley, Nelson, Tallie, & Harvey, 2014; Cherkin et al., 
2016). It is not uncommon for individuals with chronic pain to begin to abuse medication 
and ultimately move on to develop an addiction to substances that are more accessible, 
cheaper and more effective in managing pain, such as heroin (Maxwell, 2015; Weiss et 
al., 2015). 
Current prevention efforts have evaluated the factors that contribute to the 
understanding of addiction among medical professionals (e.g. education, stigma, 
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experience), resulting in programs aimed at increasing education and knowledge 
(Neufeld et al., 2012; Satterfield et al., 2012; Kotz, 2014; Ram & Chisolm, 2016). 
Understanding the relationships between physician characteristics, the ways that 
physicians address or treat chronic pain, and knowledge of opioids can contribute to 
efforts to improve addiction education by highlighting particular areas of need in 
conceptualizing pain and addiction in the medical community, thus working toward 
reducing opioid epidemic. 
Literature Review 
5 
Opioid use disorder was experienced by over 2 million Americans, ages 12 and 
older in 2015 (Center for Behavioral Health Statistics and Quality, 2016). Estimates of 
societal costs related to opioid abuse and misuse are approximately 50 billion dollars a 
year (Oderda, Lake, Ri.idell, Roland, & Masters, 2015) Prescription opioid use for 
chronic pain conditions has been identified as problematic, and can lead to addiction and 
opioid use disorder (Gladkowski et al., 2014; Compton et al., 2015). Many factors have 
contributed to physicians' uses of these medications, such as the production of synthetic 
opioids and calls for physicians to emphasize pain and pain management in treatment 
(Baker, 2016; Brady, McCauley & Back, 2016; Keefe, 2017). In the wake of the opioid 
epidemic many new policies, regulations, and prevention efforts have been put into place 
to reduce the use of opioid-based medications for chronic pain (Kampman & Jarvis, 
2015; CDC, 2016b; Joint Commission, 2017). Trends in substance use, opioid use, and 
chronic pain management will be discussed within this study, particularly as these topics 
relate to physician characteristics, pain and opioid knowledge, treatment decisions, and 
physician education. 
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Substance Use Disorders 
It is highly likely that physicians will encounter individuals with SUDs seeking 
treatment for symptoms that may be associated with substance use, due to the heightened 
risk for physical illness associated with these disorders (Mnhrer, 201 O; van Boeke! et al., 
2013). This suggests that physicians can play a key role in prevention and detection of 
problematic substance use. SUDs are a category of mental health conditions defined in 
the American Psychiatric Association's Diagnostic and Statistical Manual of Mental 
Disorders, 5th edition (2013) as a pattern of continued substance use despite significant 
negative substance related consequences, as evidenced by cognitive, behavioral and 
physiological symptoms. 
The category of SUDs contains 10 classes of substance specific disorders. Criteria 
for diagnosis of a SUD can be divided into the following four categories: social 
impairment, impaired control, risky use, and pharmacological criteria. SUDs are !mown 
to alter brain activity (Volkow, Koob, & McLellan, 2016), which may result in repeated, 
unsuccessful, efforts to stop using substances, and in drug cravings (APA, 2013). Other 
symptoms of impaired control in those with substance use disorders include: using more 
of a substance, or using a substance for a longer period of time than intended, a desire to 
cut down or stop drug use, and increased time using, obtaining, or recovering from the 
drug. Failure to fulfill obligations at home, school, or work, continued substance use 
despite negative social consequences resulting from use, and withdrawing from or 
reducing time engaging in enjoyed leisure or interpersonal activities are symptoms of 
social impairment. The third category of criteria, risky use, might involve substance use 
in physically hazardous situations or continued use despite medical or psychological 
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issues caused or exacerbated by the substance use. Last, symptoms that fall within the 
pharmacological criterion may include tolerance or withdrawal. Making a diagnosis of a 
specific substance use disorder requires a specification of symptom severity (i.e. mild, 
moderate, or severe). Additional specifiers include: in early remission, in sustained 
remission, on maintenance therapy, and in a controlled environment (APA, 2013). 
7 
SUDs are a highly prevalent issue in the U.S, specifically opioids (USDHHS, 
2016). SUDs are associated with a variety of poor individual and societal outcomes, and 
treatment knowledge and education is limited among medical professions to help address 
this issue. The National Institute on Drug Abuse reports that alcohol and tobacco, and 
illicit substances accrue major healthcare and overall societal costs (e.g. healthcare, crime 
and lost work productivity) annually, totaling approximately $166 billion and $7 billion, 
respectively (NIDA, 2016). An estimated 27.l million individuals in the United States, 
12 years or older, were identified as having used illicit psychoactive substances in a 
national survey in 2015 (SAMHSA, 2016a). In the same survey, it was found that 
approximately 6.4 million American, 12 years or older, engaged in misuse of 
psychotherapeutic drugs, which include prescription pain relievers, stimulants, sedatives, 
and tranquilizers. Substance misuse is defined by SAMHSA as, "use in any way not 
directed by a doctor, including use without a prescription of one's own; use in greater 
amounts, more often, or longer than told to take a drug, or use in any other way not 
directed by a doctor"; misuse estimates excluded the misuse of over-the-counter 
medications (SAMHSA, 2016a). These numbers also do not account for alcohol or 
tobacco use, the latter of which continues to be the leading cause of preventable death in 
the United States (SAMHSA, 2016a). Illicit substance use and substance misuse can be 
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precursors to SUDs, which were estimated to affect 20.8 million individuals in the United 
States in 2015 (SAMHSA, 2016a). 
Pharmacological and therapeutic interventions, or a combination of the two, have 
shown promise in treating SUDs; however, only a small portion of individuals with 
substance use disorders receive necessary treatment (SAMHSA, 2016a). 
Opioids: The epidemic 
Perspectives on opioid use. Perspectives on opioid use have transformed 
throughout U.S. history, vacillating between being viewed as a valuable treatment, a 
political issue, and a harmful substance of concern. Medicinal use of opioids can be 
traced as far back as 1660 (Aurin, 2000). In the early to mid-191h century in the U.S., 
opioids were a common remedy easily accessible to the public and rates of opioid use, 
including morphine, rose significantly during the Civil War (Jones, Viswanath, Peck, 
Kaye, Gill, & Simopoulos, 2018). By virtue of their respective medical philosophies, 
allopathic physicians have a long history of prescribing opioids to treat medical 
conditions effectively, but osteopathic physicians have historically avoided prescribing 
opioids; however, it is believed that differences between these two types of physicians are 
slowly diminishing (Johnson & Kurtz, 2002). It was not until the mid to late 19th century 
that treating addiction was perceived as being necessary in the medical community 
(Aurin, 2000). Initial conceptualizations of addiction were in alignment with the 
biomedical model; it was thought that nervous system functioning was perceived to be 
associated with moral behavior and social standing, and addiction was thought to be the 
cause of a weakened nervous system that could be passed from one generation to the 
next. These connections resulted in the perspective that addiction was associated with 
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moral failing, or degenerate behavior leading to "abnormal, instinctive, animal depravity" 
(Aurin, 2000). 
Opioids in the 2011' century. Earlier on in the 20th century, perspectives of addiction 
were split between those advocating a biomedical conceptualization and a moral model, 
the latter of which attributes substance use to a lack of willpower or personal 
responsibility. This had a noticeable impact on the prescription of opioids (Aurin, 2000). 
Later in the 20th century, the biomedical model gained increasingly large amounts of 
support, in part due to advancements in neuroscience. However, the moral model, is still 
quite prevalent, as discussed in the aforementioned stigma research, which evaluated how 
clinicians may find themselves making negative attributions (e.g. lacking willpower, 
being aggressive, rude, or manipulative etc.) about patients due to the presence of a 
substance use disorder (van Boeke! et al., 2013). 
Prescribing opioids in the 2P1 century. Knowledge regarding the use and associated 
risks of opium and addiction led to a decrease in its use until the end of the 20th century, 
at which point significant increases in opioid prescriptions occurred in response to 
concerns about insufficient care to manage patient pain. This new pain management goal 
became so highly emphasized within the medical community that pain itself became a 
fifth vital sign (Baker, 2016; Brady et al., 2016). As a result, opioid prescriptions have 
soared. As of2015, according to the National Survey on Drug Abuse and Health, 62.9% 
of respondents aged 12 and older reported misuse of prescription pain relievers for pain 
relief (SAMHSA, 20 l 6b ), a statistic believed to be attributed to an increase in opioid 
prescriptions for pain (CDC, 2012). In 2015, 20.5 million Americans, 12 and older had a 
SUD. Of that 20.5 million, 591,000 people had a substance use disorder related to heroin, 
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and 2 million had a substance use disorder related to prescription pain medication (Center 
for Behavioral Health Statistics and Quality, 2016). In 2013, there were 207 million 
opioid prescriptions written in the U.S. (NIDA, 2015). Unfortunately, opioid 
prescriptions are associated with a number of iatrogenic effects related to misuse, abuse 
and addiction (CDC, 2012; Weiss et al., 2014). 
Addiction to opioid can ultimately develop whether they are used as prescribed or 
misused (Weiss et al., 2014). In 2014, approximately 28,000 people died from opioid use, 
including prescription pain medication and heroin (CDC, 2016a). Additionally, since 
2003 there have been more overdoses attributed to opioid-based pain relievers than to 
heroin and cocaine combined (CDC, 2012). Furthermore, it is not uncommon for those 
that develop opioid use disorders involving prescription pain medication to begin using 
illegal drugs (i.e. heroin), at which point individuals are vulnerable to an entirely new set 
of negative outcomes, including infectious diseases acquired through injection (Maxwell, 
2015; Weiss et al., 2015). Individuals with SUDs, including opioid use disorders, have 
reported poorer quality of life ratings in regard to social, and physical well-being and 
psychological distress (Muller et al., 2016). One study of 653 individuals seeking 
treatment of prescription opioid dependence evaluated the reasons for continued use 
among those with and without chronic pain. Both groups in the study indicated that they 
began using prescription opioids to manage pain; the second noted reason for beginning 
prescription opioid use was getting high. In the chronic pain sample, the most highly 
endorsed reason for current use was to avoid withdrawal, with the second most common 
reason for current use being to manage pain (Weiss et al., 2014). This shows that, even 
among those who do not intend to abuse their medication, opioids are addictive and are 
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often used for reasons other than pain management. As such, chronic pain and its 
management through opioid-based treatments may serve as a key factor in the onset of 
opioid use disorders. 
Chronic Pain 
11 
Chronic pain is a medical condition characterized by persistent pain that continues 
beyond the time generally accepted as the appropriate healing time for a specific 
condition (International Association for the Study of Pain; IASP, 2012). Defining chronic 
pain can be complicated due to limited clarity in appropriate classification, coding, and 
diagnosis (Treede et al., 2015). Pain can be considered chronic ifit persists less than a 
month after pain begins, and as far as six months or more after pain has begun and 
anywhere in between. This is due to the variation in healing times for specific conditions 
(e.g. cancer pain versus nerve pain) (IASP, 2012). In research, six months of pain tends to 
be considered the benchmark for chronic pain; in practice, three months tends to be the 
benchmark for considering pain to be chronic rather than acute (IASP, 2012). 
Additionally, chronic pain can be found in conditions where pain persists beyond the 
healing process, when healing appears to have stopped, when normal healing has never 
occurred (e.g. osteoarthritis), or conditions in which pain seems to diminish, then and 
recurs such as chronic migraine pain (IASP, 2012). 
The IASP defines pain as, "An unpleasant sensory and emotional experience 
associated with actual or potential tissue damage, or described in terms of such damage", 
meaning that pain is a subjective experience, and that when one reports pain in a way 
consistent with tissue damage, regardless of damage itself, this should be accepted as 
pain. This definition appreciates not only the emotional impact that pain can produce, but 
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also the potential of pain being followed by psychological experiences (IASP, 2012). 
Acknowledging the subjectivity of pain in and of itself has added to the complexity and 
difficulty in treating chronic pain. Additionally, pressures on physicians to validate and 
treat patient pain in a humane way has contributed to the opioid crisis presently at hand 
(Kennedy-Hendricks et al., 2016; Van Zee, 2009; Compton et al., 2015; Wright et al., 
2014). 
12 
Chronic pain is experienced by 25 .3 million adults in the United States (NIH, 
2015), and it is the leading cause of disability, as well as the most commonly endorsed 
reason for accessing health care systems (NIH, 2010). Older individuals, females and 
non-Hispanic individuals, are at the highest risk for experiencing chronic pain and those 
who experience chronic pain are at a greater risk of depression (NIH, 2015). 
Additionally, there are high societal and work costs associated with chronic pain (Green, 
Wheeler, LaPorte, Marchant, & Guerrero, 2002). Some forms of chronic pain may 
include: headaches, neck pain, back pain, spinal difficulties, or cancer related pain, 
fibromyalgia, and phantom pain, just to name a few (Garg et al., 2012). 
Some studies suggest that treating chronic pain patients can be umewarding for 
physicians due to a number of challenges, including uncertainty about the pain diagnosis 
of the patient, insufficient time for visits or resources for pain specialists, lack of 
continuity of care, inconsistency in treatment between providers and worries about 
medication-seeking (Chen, Fagan, Diaz & Reinert, 2007), as well as the fact that attitudes 
about treating chronic pain can influence treatment recommendations (Hirsh, 
Hollingshead, Bair, Matthias & Kroenke, 2014). 
In one study of 110 internal medicine residents, 63% of participants reported 
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feeling "somewhat" or "much less confident" about treating patients with chronic 
norunalignant pain than about treating patients diagnosed with diabetes. In the same 
study, 48% and 91 % of physicians indicated that it was "somewhat" or "much more 
difficult", respectively, to treat patients with chronic norunalignant pain when compared 
with treating diabetes for previous patients and patients who were referred (Chen et al., 
2007). 
Chronic pain treatment. In the past 20 years or so, the medical community has 
paid particular attention to chronic pain management due to the pervasiveness of chronic 
pain issues in society. The current system for classifying chronic pain is the International 
Classification of Diseases 10th Revision (ICD-10). It is argued that this framework lacks 
organization and acknowledgment of etiology, thus complicating advances in treatment 
and patient care (Treede et al., 2015). The International Association for the Study of Pain 
aims to address this issue in the upcoming 11th Revision of the ICD by proposing that 
pain be classified on the three following aspects of pain, in the order in which they are 
listed: etiology, underlying pathophysiological mechanisms, and last, location on or in the 
body. This new classification system divides the most common chronic pain disorders 
into 7 categories: chronic primary pain, chronic cancer pain, chronic posttraurnatic and 
postsurgical pain, chronic headache and orofacial pain, chronic visceral pain, and chronic 
musculoskeletal pain. Chronic pain severity is assessed by evaluating the intensity of the 
given pain, as well as the associated distress and functional impairment caused by the 
pain. This new system can improve both research and practice associated with treatment 
(Treed et al., 2015). 
There is no one standard treatment for chronic pain due to the variability in 
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presentation and/or patient experience. Nevertheless, there are some treatments that have 
been shown to be effective for a wide range of chronic pain sufferers. Treatments for 
chronic pain range from pharmacological interventions, to lifestyle changes and 
psychological interventions (Garg et al., 2012; NIH 2015; Cherckin et al., 2016; 
Gladkowski et al., 2014). The pain management strategies discussed within the context 
of the current study are associated with varying degrees of evidence in chronic pain 
literature. Nonetheless, the various alternative treatment approaches are representative of 
the numerous strategies for managing pain outside of opioid use, and other potential 
avenues for future pain management research. It should be noted that this is not a 
comprehensive list. 
Pharmacological treatment. 
Opioids. Opioids have long been used to relieve pain, in addition to a number of 
other health issues (Aurin, 2000; Maxwell, 2015). There are times when opioid are 
clinically indicated, for example with: acute pain, cancer pain, or palliative care. There 
are multiple guidelines available to professions to help determine whether or not opioids 
based treatments are appropriate (Kampman & Jarvis, 2015; CDC, 2016b). Conversely, 
even with the risk of substance use aside, there is limited evidence for the efficacy of 
opioid treatment in the management of chronic pain conditions, such as chronic low back 
pain (Gladkowski et al., 2014). Furthermore, there are a number of alternative treatment 
options that could be helpful for patients, with a lower potential for addiction and SUDs. 
Nonsteroidal anti-inflammatory drugs. Nonsteroidal anti-inflammatory drugs 
(NSAIDs), are a commonly used, non-narcotic class of pharmacological options for the 
treatment of chronic pain. NSAIDs are intended to reduce pain and overall disability 
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associated with chronic pain conditions. Research on the use ofNSAIDs for chronic low 
back pain, unlike opioid-based medications, show limited evidence of adverse events 
associated with use (Derry, Da Silva, Wiffin, & Moore, 2016; Enthoven, Roelofs, & 
Koes, 2017). Findings from one meta-analysis suggest topical NSAIDs having a higher 
rate of adverse events when compared with oral NSAIDs, and that topical placebos show 
greater clinical success than oral placebos. However, there is low-quality evidence for the 
use ofNSAIDs in the treatment of chronic low back pain, osteoarthritis and other pain 
conditions, with evidence for topical NSAIDs in the use of osteoarthritis showing "good 
level of pain relief .. .in osteoarthritis for a minority of people" (Derry et al., 2016; 
Enthoven et al., 2017). Discrepancy between the efficacy of these medications and their 
use in the management of chronic pain suggests the need for better, more effective pain 
management strategies. 
Benzodiazepines. Anxiety and depression are common comorbid conditions for 
those who struggle with chronic pain (Castro et al., 2009). Benzodiazepines can be used 
as muscle relaxants or anxiolytics; however, much like opioids, they have a high 
addictive potential. Furthermore, these medications do not address pain management 
directly, and are associated with poor physical and mental health outcomes with 
increased use and when in combination with opioid pharmacotherapy (Gauntlett-Gilbert, 
Gavriloff, & Brook, 2016). Benzodiazepines are generally contraindicated for the 
management of chronic pain (CDC, 2016b), and it is important for physicians to be aware 
both of medication benefits and of risks when discussing pharmacological interventions 
for chronic pain; this is the reason why this class of medication is referenced here and 
within the present study. 
PHYSICIANS' USE OF PAIN MANAGEMENT STRATEGIES 16 
Psychological treatment 
Cognitive behavioral therapy. CBT is a psychological approach that can be used 
to treat individuals with a variety of physical and mental health issues, including chronic 
pain and associated comorbidities (e.g. depression). This approach, in line with the 
biopsychosocial model of care, considers biological, emotional, and environmental 
factors that influence an individual (Engel, 1980), while increasing coping and reducing 
psychological distress (Knoerl, Smith, & Weinberg, 2016). Aspects of cognitive 
behavioral treatment may include: relaxation techniques, activity scheduling, sleep 
hygiene, increasing positive coping, and the identification and modification of 
problematic thoughts and behaviors. Additionally, CBT is believed to have a positive 
physiological and neurological impact for individuals with chronic pain (Knoerl et al., 
2016; Morasco et al., 2016; Nicholas et al., 2017). One meta-analysis of 35 studies aimed 
at addressing the use of CBT in treating chronic pain found several relevant findings. 
Most notably, CBT was effective in reducing pain intensity in 43% of trials. At a 6 month 
follow up, it was found that 36% of respondents reported reductions in pain intensity, and 
online CBT may be as effective as individual CBT. Furthermore, the interventions were 
effective in improving sleep, fatigue, depression and anxiety in 50% of cases, and that 
findings associated with CBT may be hampered by an inadequate amount of randomized 
controlled trials (RCTs) or consistency in treatment frequency, intensity, and duration 
(Knoerl, Smith, & Weisberg, 2016). 
Another study (Morasco et al., 2016) sought to develop a cognitive behavioral 
program for individuals with hepatitis C who also struggled with a substance use, chronic 
pain, and depression. In this study, 21 participants, over the course of 8 weeks and 8 
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sessions, were educated about: (1) chronic pain, (2) identifying automatic thoughts and 
engaging in cognitive restructuring, (3) increasing pleasant activities, (4) pain 
communication, ( 5) pain medication, ( 6) sleep hygiene, and (7) relapse prevention. At the 
end of the study, and at three-month follow up, reductions in pain severity and 
interference in daily functioning significantly declined. However, there were no 
significant changes in depression or drug and alcohol cravings (Morasco et al., 2016). 
This study is somewhat limited by its small sample size and non-experimental design, but 
it reiterates the complexity of chronic pain conditions, the importance of non-
pharmacologic options for chronic pain, and difficulty in addressing SUDs. Overall, 
research for CBT as a stand-alone, or adjunct therapy in the treatment of chronic pain is 
promising. 
Mindfulness and meditation. Meditation and mindfulness are practices 
increasingly common in W estem culture and are derived from Eastern medicine. These 
practices are associated with reduced stress and pain, as well as with improved emotional 
well-being and quality oflife (Peterson & la Cour, 2016; Hilton et al., 2017), engagement 
in life activities, willingness to experience pain, and subjective measures of pain (Beaulac 
& Bailly, 2015). Thomas & Garland (2017) studied 115 individuals receiving opioid 
pharmacotherapy to address chronic pain, and the influence of state and dispositional 
mindfulness on hedonic capacity. The authors note that it is common for individuals who 
use opioids or who experience chronic pain to experience anhedonia, which is a loss of 
the ability to gain pleasure (Thomas & Garland, 2017). They found that mindfulness 
practice was associated with increased hedonic capacity, thus it may be a beneficial 
treatment for individuals with chronic pain, particularly those who use opioid-based 
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medications (Thomas & Garland, 2017). Increasing hedonic capacity could also be 
helpful in addressing comorbid conditions, such as depression, during which individuals 
struggle to experience pleasure in events that may have previously been enjoyable. 
Mindfulness based stress reduction (MBSR) is a psychological treatment that focuses on 
observing and describing internal and external stimuli in a non-judgmental way, with 
acceptance; this allows an individual to focus on the present moment, approach a 
situation with greater clarity and reframe his or her thoughts (Hilton et al., 2017). One 
systematic review of 30 studies that assessed patients with osteoarthritis, fibromyalgia, 
migraine headaches, other types of headaches and unspecified pain, found that 
mindfulness meditation was associated with reduced pain symptoms, when compared 
with treatment as usual (e.g. support groups, education on pain). This review also found 
high, medium and low statistically significant effects of mindfulness meditation on 
depression, mental health quality of life, and physical health quality of life, respectively 
(Hilton et al., 2017). Other notable benefits to MBSR or meditation-based treatments are 
the cost-effectiveness and low risk associated with these practices (Peterson & la Cour, 
2016). 
Biofeedback. Biofeedback is a psychological intervention that can be combined 
with other approaches, such as CBT or physical therapy, whereby patients learn to 
regulate physiological processes through training (Flor, Haag, & Turk, 1986; Sielski, 
Rief, & Glombiewski, 2017). In training, patients are provided with cues (e.g. auditory, 
visual, or tactile) that provide information about processes in the central nervous system. 
Ultimately, patients learn to identify and influence these processes. This is relevant for 
chronic pain because individuals who can identify and influence physiological processes 
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may have greater control over their pain experiences, including cognitive and behavioral 
associations (Flor et al., 1986; Sielski, Rief, & Glombiewski, 2017). Biofeedback can 
also be an effective treatment for traumatic injury, sleep disturbance, anxiety, and 
depression (Whitney, 2014). Electromyographic (EMG), respiratory, brainwave, heart 
rate, sweat gland, and temperature biofeedback modalities can be used to treat patients, 
with EMG and heart rate or respiratory biofeedback being the most common for chronic 
pain treatment (Whitney, 2014; Sielski, Rief, & Glombiewski, 2017). A meta-analysis 
including 21 studies comprising 23 treatment conditions, involving 1062 participants 
found small to medium effect sizes for all outcomes measures reviewed; these included: 
pain intensity, disability, depression, cognitive-coping, and reduction in muscle tension. 
These findings were replicated when analyzing controlled studies alone, with the 
exception of pain intensity, which went from a medium to a small effect size. 
Additionally, these results were retained at long-term follow-up, although this did vary 
between studies (Sielski, Rief, & Glombiewski, 2017). The authors of this analysis 
acknowledge that there is limited research on biofeedback as a treatment for chronic pain 
and that there is a need for randomly controlled trials (RCTs) to build upon the current 
support. They also observed that longer treatments, and a greater proportion of 
biofeedback built into the treatment was associated with reductions in disability caused 
by pain and depression, respectively (Sielski, Rief, & Glombiewski, 2017). Biofeedback, 
as with other treatment modalities, may require a different level of time commitment as 
compared with pharmacological approaches; however, biofeedback appears to have far 
fewer iatrogenic effects and the research discussed in this dissertation indicates that it can 
be helpful on its own or as a supplement to other psychological or physiological 
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approaches (e.g. manipulative therapy, physical therapy). 
Complementary and Alternative treatments. 
Physical therapy. One study conducted two separate meta-analyses to compare 
opioid therapy with exercise therapy, or physical therapy, in the treatment of chronic low 
back pain (Gladkowski et al., 2014). The authors noted that there is little research directly 
comparing these treatment modalities, which is problematic in itself. The researchers 
found that data support the use of physical therapy and that physical therapy is, overall, 
slightly to moderately effective. Conversely, they found limited and conflicting evidence 
for the efficacy of opioid therapy in treating chronic low back pain, particularly over time 
(Gladkowski et al., 2014). Another study evaluating the treatment of chronic pelvic pain 
syndrome after pelvic floor physical therapy with an internal myofascial trigger point 
wand found that, at 6 month follow-up, a statistically significant (p < 0.001) number of 
the 374 study participants discontinued medication (Anderson, Harvey, Wise, Smith, 
Nathanson, & Sawyer, 2015). This exemplifies the multiple forms of chronic pain that 
can be treated with physical therapy. 
Nutritional counseling. Nutritional interventions for chronic pain have received 
increased attention in recent years as a possible adjunct approach to chronic pain 
treatment. Importantly, the evidence for nutritional intervention is mixed but does 
warrant further research (De Gregori et al., 2016; Brian et al., 2019). For example, Cairns 
(2016) explored the relationship between chronic pain and four food additives (i.e. 
monosodium glutamate, aspartame, arachidonic acid, and caffeine). Findings suggest that 
reduced consumption of these substances does not consistently result in reduced pain, and 
there is limited evidence for how these foods may be associated with an increase in pain 
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(Cairns, 2016). Conversely, some nutritional compounds are argued to have an anti-
inflammatory and/or analgesic effect, such as omega-3 fatty acids and soy that could 
benefit those suffering with chronic pain (De Gregori et al., 2016). It is also argued that 
comorbid conditions, such as obesity, depression, anxiety, and cardiovascular disease are 
also associated with chronic pain, and that nutritional changes can facilitate positive 
health outcomes within these comorbidities, leading to pain related improvements (Brian 
et al., 2019). A systematic review ofliterature assessing perceived pain and nutritional 
interventions through 71 studies that provided qualitative information, and 23 studies 
included in the meta-analysis identified four broad categories of nutritional intervention: 
altered dietary pattern, altered specific nutrients, supplements, and fasting therapy. 
Analyses found statistically significant reductions in pain for all but fasting therapy, with 
a more healthful eating pattern having the greatest effect in reducing pain (Brian et al., 
2019). Another article likens nutrition to sleep and exercise, all factors that contribute to 
overall health, and should be considered routine within medical evaluations. They argue 
that there is a relationship between pain and specific nutrients (e.g. polyamines, omega-3 
and omega-6 PUFAs, vitamin D, and caffeine), but acknowledge that more research is 
necessary to support this link (Bell, Borzan, Kalso, & Simonne!, 2012) 
Chiropractic treatment. Chiropractic treatment is a complementary medicine 
approach that has shown some efficacy in the treatment of some chronic pain conditions 
(Sherman, Cherkin, Deyo, Erro, Hrbek, Davis, & Eisenberg, 2006; Wilkey, Gregory, 
Byfield, & McCarthy, 2008; Peterson, Bolten, & Humphreys, 2012; Haavik, Niazi, Holt, 
& Murphy, 2017). Chiropractic care can involve a number of treatments, including: 
Musculoskeletal manipulation (e.g. manipulation of the lumbar spine and pelvis for low 
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back pain), flexion distraction, trigger points, stretching techniques, ischemic 
compression, dry needling, post-isometric relaxation stretching, soft tissue massage, and 
other resistance stretching techniques, to name a few (Wilkey et al., 2008). In one small 
study (N = 27) comparing treatment as usual in a pain clinic (e.g. any singular or 
combined treatment with NSAIDs, analgesics, gabapentin, facet joint injections, soft 
tissue injections, and transcutaneous electrical nerve stimulation machines) to 
chiropractic care, including one or more of the aforementioned chiropractic techniques, 
there was a statistically significant effect for the use of chiropractic treatment (Wilkey et 
al., 2008). Specifically, individuals both in the pain center and in chiropractic groups 
showed a reduction in disability, with those who received chiropractic treatment showing 
a clinically and statistically significant reduction in disability when compared with the 
pain center group. Additionally, there was a statistically significant reduction in 
perceived pain score in the chiropractic treatment group at the end of the 8-week study; 
scores for the pain center group were slightly elevated, but not significantly. An 
interesting difference between these two groups that should be noted is that the 
chiropractic care group attended an average of 11.3 sessions, but the pain center group 
attended an average of 1.9 sessions (Wilkey et al., 2008). This differential brings to light 
the importance of individualized care and taking into consideration a patient's ability to 
commit to any given treatment that may be prescribed. The generalizability of this study 
is limited by sample size and potential inconsistency within treatments (e.g. both the 
chiropractic and pain center groups could use any combination of treatments they may 
usually provide, non-equivalent groups), but it does give direction for future research on 
the efficacy of chronic pain treatment and adds to a growing body of research that 
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supports chiropractic care as a lower risk alternative treatment for chronic pain as 
compared with some other modalities, such as opioids (Sherman, Cherkin, Deyo, Erro, 
Hrbek, Davis, & Eisenberg, 2006;Wilkey et al., 2008; Noertjojo, Martin, & Dunn, 2010; 
Peterson, Bolten, & Humphreys, 2012; Haavik et al., 2017). 
Acupuncture. Acupuncture treatment has traditionally involved the insertion of 
needles into the skin at relevant pressure or trigger points to redirect and resolve issues 
with the flow of energy (i.e. qi) and blood. This practice, which originated in Chinese 
medicine, has become increasingly common as a complementary and alternative 
approach to addressing health issues in places where westernized practice is predominant 
(Wan, Wang, Xue, Wang, Liang, & Zheng, 2015). Although there has been controversy 
regarding the effectiveness of acupuncture, research is beginning to have greater success 
in identifying the physiological mechanisms that support acupuncture as a treatment 
modality. Specifically, acupuncture has been found to impact the endogenous opioid 
system and central nervous system in the body. Positron-emission tomography scans 
show short and long term changes in the limbic system, such as increased opioid binding 
potential, after acupuncture treatment; furthermore, other imaging studies have shown 
deactivation of areas in the brain that respond to pain stimuli. These structures are part of 
the limbic system and include, the arnygdala, hippocampus and cingulate (Dorsher, 
2011). Systematic reviews ofrandomized controlled trials suggest that acupuncture 
treatment shows clinically significant and statistically moderate effects over usual care 
(e.g. education about chronic pain, treatment options, and information about guidelines 
for medication and dosages), and sham acupuncture (e.g. needles that don't go under the 
skin to control for the documented placebo effect of acupuncture) in the treatment of a 
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several pain conditions, particularly low back pain, neck pain, and chronic 
musculoskeletal pain (Inoue, Rojo, Nakajima, Kitakoji & Itoi, 2009; Dorsher, 2011; 
Vickers et al., 2012; MacPherson, Maschino, Lewith, Foster, Witt, Vickers, 2013; Wan et 
al., 2015). Some chronic pain conditions may not benefit from acupuncture. For example, 
there is low to moderate evidence for the use of acupuncture in fibromyalgia treatment 
(Deare, Zheng, Xue, Lui, Shang, Scott, & Littlejohn, 2013). Acupuncture in general is a 
low risk treatment, compared even to more traditional treatments such as NSAIDs. It 
would be beneficial to conduct more research relating to dosage and frequency of 
treatment in order to achieve the best medicinal effect (MacPherson et al., 2013). 
Treatment overview: The treatments reviewed within this study have been 
discussed as separate and stand-alone options; it is important to note that the most 
effective treatment for chronic pain is often multidisciplinary and multimodal (CDC, 
2016b). Although more research is necessary to discern the most potent and safe 
treatment, it is clear that it is important for healthcare providers to communicate with one 
another to provide the most effective treatment, based on the needs of the patient 
(Grandhe, Souzdalnitski, & Gritsenko, 2016). In a brief overview of treatment efficacy 
and physician considerations, Kroenke, & Cheville (2017) indicate that there are 
effective, nonpharmacologic options for chronic pain, although some patients may have a 
hard time maintaining well supported alternative treatments for chronic pain, such as 
CBT, and that opioid analgesics may be necessary, particularly when weighing the risks 
and efficacy of other analgesics (i.e. acetaminophen and NSAIDs). The authors also point 
out that placebo effects, which range from 30-50% should not be discounted due to 
potentially positive cognitive and physiological outcomes (Kroenke, & Cheville, 2017). 
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Essentially, continued research, individualized patient care (e.g. symptoms and diagnosis, 
patient abilities, level of access to care), multidisciplinary and multimodal treatment, and 
physician knowledge of treatment options can improve the current state of chronic pain 
treatment. 
Chronic pain and opioids: A closer look. One analysis suggests that 
prescription opioid use is declining; however, heroin use is on the rise and that these 
trends are related; moreover, this phenomenon is in contrast to other illicit substances, 
such as cocaine, which have been declining in use over time (Maxwell, 2015). Although 
not all heroin use can be attributed to a shift away from prescribed, or non-prescribed 
pharmacologic opioids, some studies suggest that a large portion of heroin users report 
beginning to use heroin after becoming addicted to prescription opioids (Jones, 2013; 
Maxwell, 2015; Muhuri, Gfroerer, Davies & 2013; Pollini et al., 2011). In one study, 
only 1 % of individuals addicted to prescription pain medication reported having used 
heroin prior to their prescription-based opioid use disorder (Muhuri et al., 2013). 
In addition to the potential risks of opiate consumption for individuals with 
chronic pain, physicians may also experience adverse consequences associated with 
opioid treatment expectations of patients, or lack of effective treatment options. Chen et 
al. (2007) found that a significant percentage of the 110 internal medicine residents 
surveyed had a patient leave their practices (74%), had discharged a patient from his or 
her practice (35%), or had been threatened by a patient within the practice (38%) due to 
conflicts associated with opioid prescriptions. 
In response to concerns around opioid use, new initiatives are underway to help 
physicians and physicians in training balance the treatment needs of patients with the 
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risks of substance use disorders and opioid prescription misuse. Some of the efforts 
aimed at developing more effective, and safer pain management strategies include: 
research into the genetic factors that may impact the experience of pain (NIH, 2010), an 
app created to provide physicians with CDC guidelines for opioid prescriptions when 
treating pain patients (CDC, 2016c), research into complementary and alternative 
treatments being incorporated into medical programs, and education programs addressing 
substance use and chronic pain identification and intervention (NIH, 2010; Abbott et al., 
2011; Neufield et al., 2012; Satterfield et al., 2012). 
The Role of Physicians 
The opioid epidemic, much like prior drug epidemics, occurred as a result of 
several influencing factors, including physician efforts to manage pain more effectively. 
However, before this emphasis in practice, there were developments in the 
pharmaceutical industry, a shift in focus to address patient pain, and subsequent 
requirements and mandates to do so. In fact, much of the blame for the current social, 
financial, physical, and emotional toll of the opioid epidemic is being placed on 
pharmaceutical companies for failure to represent, accurately, the dangers associated with 
their products, leading to lawsuits on local and state levels (Van Zee, 2009; Addy, 2017; 
Keefe, 2017; Schottenfeld et al., 2018). Just as physicians receive some of the blame for 
the current epidemic, they are also given significant responsibility in remedying the over 
reliance or use of opioid medications and addressing the negative consequences of opioid 
use. As a result, research focusing on physician characteristics as these relate to the 
prescription of opioid based pain relievers is valuable in order to assist other emerging 
and existing medical professionals. 
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Physician Edncation. Historically, physicians have reported feeling 
underprepared to help patients manage chronic pain or SUDs due to undertraining, which 
is compounded by negative treatment outcomes associated with stigma related to 
substance use and finding treatment of chronic pain umewarding (Chen et al., 2007; 
Hirsh et al., 2014; Meltzer et al., 2013; Avery, 2016). Updates to federal guidelines, 
changes to requirements and opportunities made by licensing bodies, academic program 
updates, and increases in resources on these topics suggest that physicians will have 
significantly more opportunities to learn about chronic pain, substance use, and opioid 
based medications. 
The CDC Guidelines for Prescribing opioidsfor Chronic Pain (CDC, 2016b) and 
ASAM's National Practice Guideline for the Use of Medications in the Treatment of 
Addiction Involving Opioid Use (Kampman & Jarvis, 2015) are two examples of recent 
guidelines set into place to provide direction and to support physicians in the mitigation 
of the dangers of opioids while providing comprehensive treatment to individuals with 
chronic pain and opioid use disorders, respectively. The Joint Commission, an 
organization responsible for accrediting and certifying healthcare programs and 
organizations, received such significant backlash for their perceived roles in the 
development of the opioid epidemic due to their 2001 pain assessment and treatment 
guidelines that they delivered a press release in their defense in 2016 (Baker, 2016). The 
following year, they announced new revised assessment and management standards for 
pain for accredited hospitals (The Joint Commission, 2017). Improved efforts to address 
barriers to effective treatment have led to initiatives to update training expectations in 
schools and in continuing education requirements for existing professionals as well. 
PHYSICIANS' USE OF PAIN MANAGEMENT STRATEGIES 28 
Major changes have occurred in just the past few years. In 2016, the American Board of 
Preventive Medicine (ABPM) announced that in 2017, physicians certified by a board of 
the American Board of Medical Specialties (ABMS) would be given the opportunity to 
be certified in addiction medicine, a subspecialty first recognized by ABMS in 2015. This 
same year, the American Council for Graduate Medical Education approved fellowship 
training in this field. Prior to these changes, addiction medicine was best accounted for by 
addiction psychiatry (ABPM, 2016; Schottenfeld et al., 2018). Educational changes in 
medical schools that challenge the use of opioids when they are not warranted and 
encourage increased use of alternative evidence-based treatments lends to the hope that 
emerging physicians will feel better equipped to manage challenges of working with 
patients experiencing chronic pain and/or problematic opioid use following medical 
school, compared with their predecessors who may have had the opportunity to receive 
this education through continuing education alone. Challenges related to continuing 
education will be discussed. 
There are some perceived concerns related to the implementation of new 
guidelines alone, without education; this is due to how realistic guidelines are perceived 
to be in actual practice, and how effective they will be in addressing patient needs 
(McCalmont, Jones, Bennett & Friend, 2018). One study evaluating physicians and nurse 
practitioners in Oregon found a significant gap between Oregon's endorsement of CDC 
guidelines and physician adherence to, or implementation of them. Although 91 % percent 
of physicians reported familiarity or having read the guidelines, only 57% of participants 
reported having used the guidelines in practice. A variety of conclusions can be drawn 
from this information. The authors of this study suggest that continuing medical 
PHYSICIANS' USE OF PAIN MANAGEMENT STRATEGIES 29 
education, in addition to guideline familiarity alone, may be required for guidelines to be 
reinforced and put to practice (McCalmont et al., 2018). Furthermore, the authors found 
a positive relationship between CME hours and confidence in pain management and 
implementation of these guidelines. There are additional challenges with acquisition of 
updated knowledge through continuing medical education for pain management and 
substance use treatment as well. One study assessed state requirements for general 
continuing education and pain specific continuing education. It was found that, as of 
2015, only 5 states required almost all physicians to complete pain management 
continuing education on controlled substance prescription, pain management or substance 
use disorders, and 23 states required "some" physicians to complete continuing education 
in these areas. Regarding general CME requirements, only 46 states and the District of 
Columbia require physicians to complete some continuing education in order to maintain 
licensure. This suggests that, although CMEs courses may be effective in building upon 
knowledge gained in medical school, they are helpful only if they are utilized and that 
CME credits are not a replacement for education in medical schools (Davis & Carr, 
2016). A survey conducted by the American Medical Association (AMA) found that 68% 
ofrespondents had completed CME courses on safe opioid prescribing practices and 55% 
had completed courses on pain management with opioid alternatives. One in four 
respondents noted feeling as though the opportunities for education in these areas were 
not relevant to their practice or specialty (AMA, 2016). These numbers are of some 
concern, given the importance and potential risks to patient health, associated with 
opioids and pain management. 
One CME program that could provide more opportunities for medical 
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professionals is SCOPE (Safe and Competent Opioid Prescribing Education) of Pain, 
which was developed in response to the United States Food and Drug Administration 
(FDA) Risk Evaluation and Mitigation Strategy (REMS). This requires that 
manufacturers of extended release and long acting opioid medications jointly fund 
training for prescribers in order to educate them about safe use of these medications with 
the inclusion of predetermined topics (i.e. Blueprint for Prescriber Education for 
Extended-Release and Long-Acting Opioid Analgesics or FDA Blueprint). The SCOPE of 
Pain program is the first of this specific kind of risk evaluation and mitigation strategy 
programs. SCOPE of Pain can be completed in 3 hours online or live; it aims to 
incorporate clinical scenarios and education on opioid prescribing, a risk benefit 
framework, communication, team-based care, and skills for the assessment and 
management of medication taking behaviors (Alford, Zisblatt, Ng, Hayes, Peloquin, 
Hardesty, & White, 2016). An initial study of this program, which included physician 
assistants, physicians, and advanced practice nurses showed significant improvements in 
knowledge and attitudes (e.g. knowledge of opioid prescribing practices and pain, 
confidence in opioid prescribing, communication and guidance of patients in treatment, 
positive changes to practice, increased trust in chronic pain patients, increased trust in 
tools for pain and opioids). At two-month follow up, these improvements were less 
significant, but still above baseline (Alford et al., 2016). It is noteworthy that there were 
2,850 participants in the initial target group, and ultimately 476 participants were retained 
at the two months follow-up. This again exemplifies how training can be beneficial, if it 
is completed. Government REMS in pain management have received some criticism as 
well. In an ethics forum published in Pain Management, a physician in agreement with 
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mandatory pain management CME courses and one who opposes the courses share their 
perspectives. The former endorses the benefit of mandatory CME courses due the need 
for pain management, medication diversion, opioid, and addiction knowledge, and argues 
that mandatory CME courses with appropriate content through accrediting bodies avoids 
issues where conflicts of interest may be unclear. The physician opposing mandatory 
CME courses expresses concerns that physicians may stop prescribing opioids all 
together if they are required to take a CME course in order to prescribe and that there are 
a number of topics that physicians are already required to be informed of in order to 
provide quality care (Schatman & Darnall, 2013). This information is important; although 
we know that CMEs are a requirement for some at this time, and that CMEs increase 
knowledge, these are the concerns that physicians working directly with patients may 
have. Controversy around CMEs, and hesitancy to take them, could contribute to those 
that have more recently graduated from medical school in a time of increased focus on 
opioids and pain management becoming more fully educated and equipped to treat 
patients with related issues. 
Regarding required education in Pennsylvania, where the present study was 
conducted, doctors of medicine (MDs) and doctors of osteopathic medicine (DOs) are 
required to obtain 100 hours of continuing education every two years in order to renew 
their medical licenses. Of these 100 hours, 12 hours must be devoted to patient safety and 
risk management and 2 must be devoted to mandated child abuse recognition and 
reporting (Harvan, 2018). Following Act 124 of2016, those seeking initial licensure in 
the 2017-2018 licensure period are required to complete "at least two hour of education 
in pain management or identification of addiction and at least two hours of education in 
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the practices of prescribing of opioids'', which can be accrued through CMEs or a degree 
program. Those seeking re-licensure must complete "at least two hours of continuing 
education in pain management, identification of addiction, or the practices of prescribing 
of opioids"; those that do not have their own DEA registration numbers or who do not 
prescribe controlled substances in any way are exempt from these requirements 
(Pennsylvania Medical Society, 2018). It seems possible that the increased hour 
requirement for those seeking initial licensure may facilitate the possibility of newer 
graduates being more fullly informed on pain management, opioid prescription, and 
substance use. 
In one study, substance use disorders had a higher rate of detection in the teaching 
service sector of a community teaching hospital, when compared with non-teaching 
hospitalists in the same facility. The authors suggest that this finding, in part, may be 
attributable to the number of providers on a teaching team, allowing more opportunities 
for detailed charting, questioning, and SUDs symptom identification (Holt et al., 2013). 
These findings may provide clues about physician characteristics that positively impact 
the care of patients presenting with substance use. Notably, within this study, teaching 
teams were led by an attending physician and included one junior or senior medical 
resident, one intern, and 1-2 students (Holt et al., 2013). An alternative hypothesis that 
may account for this, one which is raised in this study, is that those who graduated more 
recently and received medical education in the midst of the current opioid epidemic, may 
be better equipped to detect and prevent substance use disorders. 
Physician Specialty and Other Relevant Variables. Much of the research on 
demographics and physician prescribing practices looks at patient characteristics. In 
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recent years, there has been an increased focus on physician specialty and opioid 
prescribing practices, with an emphasis on primary care and emergency department 
physician practices, given their contact with chronic pain patients (Hoppe, McStay, Sun, 
& Cap, 2017; Barnett, Olenski, & Jena, 2017). A number of patient factors can contribute 
to opioid prescribing. One study of Medicaid beneficiaries found that patients identified 
in the study as Black were less likely to receive opioid prescriptions than those identified 
as White; this difference was particularly significant for the following physician 
specialties: obstetrics/gynecology, internal medicine, and general practice/family 
medicine (Ringwalt, Roberts, Gugelmann & Skinner, 2015). These findings have been 
supported in other studies as well (Hoppe et al., 2017) and further suggest that physicians 
may be inclined to make treatment recommendations based on their past experiences, 
biases, or individual interpretations. Variability in recommendations was further 
demonstrated in and analysis of treatment recommendations for pain made among 
emergency department physicians, where practitioners were largely consistent within 
their responses to three vignettes, but there was high variability between physicians 
(Tamayo-Sarver, Dawson, Cydulka, Wigton, & Baker, 2004) and among emergency 
department physicians treating low back pain (Hoppe et al., 2017) 
There is less recent research related to physician demographic variables (e.g. age, 
gender, recency of graduation, specialty etc.) as they relate to opioid prescribing 
practices, opioid knowledge, or use of alternative treatments. Investigations into 
physician specialty that are available have mixed results (Ringwalt, et al., 2014). In an 
effort to clarify the role that physician specialty has on opioid prescription, 73 ,487 
prescriptions for Medicaid patients with chronic noncancer were assessed to determine 
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prescriber specialty. All specialties included were: ENT, dentistry, general practice and 
family medicine (GP/FM), internal medicine, emergency medicine, orthopedic, OBGYN, 
among others. Among these specialties, orthopedics, dentists, and emergency medicine 
physicians had the highest rates of opioid prescriptions, with little to no differences 
between or among the other specialties. Notably, a greater proportion of overall 
prescriptions were provided by GP/FM physicians, which is accounted for in this study 
by the greater frequency with which patients with chronic pain see providers in this 
category (Ringwalt et al., 2014). Ongoing research into the role that specialty plays in 
opioid prescription can provide direction in continuing education, certification practices, 
and medical training both for chronic pain and for addiction treatment. The present study 
aims to build upon this research by assessing relationships between physician specialty, 
opioid knowledge, and use of alternative treatments. 
Purpose of Study 
Current research regarding physicians treating addiction suggests that medical 
professionals as a whole are less likely to provide effective treatments to individuals with 
substance use disorders if those professionals have had limited experience and education, 
or high levels of stigmatizing attitudes towards substance users (van Boeke! et al., 2013; 
Ram & Chisolm, 2016). Similar findings have been discussed in relation to chronic pain. 
Despite this knowledge, the field is only beginning to examine how physician factors, 
such as specialty or recency of graduation contribute to their uses of alternative 
treatments to opioids in chronic pain management or opioid knowledge. It is clear that 
there is an increased push for medical education to address addiction and pain 
management more effectively, and that the physicians gain a significant portion of their 
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lmowledge through medical schooling. It is also known that there is a greater emphasis 
on opportunities for continuing education on pain management and assessment, opioids, 
and addiction, and greater opportunities for specialization in addiction medicine, and 
increased knowledge positively impacts practice. 
Taken altogether, the proposed study aimed to evaluate the relationships between 
recency of graduation, physician specialty, and other physician factors as they relate to 
opioid knowledge and opioid/non-opioid treatment recommendations for a hypothetical 
patient with chronic pain. First, it was hypothesized that there would be a negative 
correlation between years since graduation and opioid knowledge. Second, it was 
hypothesized that there would be a significant and negative relationship between years 
since graduation and amount of non-opioid treatments recommended to the patient in the 
vignette. In addition to these hypotheses, this study explored the relationships between 
several demographic variables (i.e. physician specialty, biological sex, and race), and 
opioid knowledge and number of alternative treatments endorsed, with no directionality 
specified. 
The positive relationship between degree of substance use knowledge and 
physician treatment of patients with SUDs is well established (Ram & Chisolm, 2016; 
Neufield et al., 2012). Research supports the idea that opioid-specific knowledge, 
including appropriate prescribing practices and risk potential has a positive impact on 
treatment of chronic pain as outlined within this study. Less is known about physician 
variables as they related to opioid knowledge, which could influence the frequency or 
quantity of opioid or non-opioid treatment recommendations for managing pain. There 
may be a relationship between physician variables and opioid knowledge and specific 
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treatments selected as well (e.g. low knowledge, opioid endorsement). For example, new 
graduates may have received more extensive training regarding opioids due to a recent 
call for substance use and pain management education and training in medical programs 
in response to the opioid crisis (Neufield et al., 2012; Satterfield et al., 2012; Ram & 
Chisolm, 2016), which may influence physician knowledge and treatment selections. 
Alternatively, time and experience with patients, regardless of opioid knowledge, may 
lead to physicians being more, or less, inclined to recommend certain treatments based on 
clinical intuition or observations, a challenge new guidelines are faced with (Kahn et al., 
2019). Even improved educational goals may not equate to practice differences. 
Guerrasio et al., (2014) argue that despite higher standards and an increase in measures 
for student performance, many of these measures in medical education are subjective, and 
even those students who may not meet the expectations of medical programs are 
infrequently dismissed from their respective programs, resulting in, and "failure to fail". 
Satterfield et al., (2012) also acknowledge the difference between attitudes and 
knowledge versus changes in clinical skills, and the importance of evaluating both when 
providing substance use education. Additionally, if recency since graduation amidst 
major educational reform initiatives is not correlated with treatment and knowledge, it 
would further support the possibility that other physician characteristic, such as specialty, 
would be related to these decisions. This study aims to assess the relationships between 
recency of graduation, physician treatment selections, opioid knowledge, and physician 
specialty to evaluate these scenarios further. 
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Chapter 2: Research Question and Hypotheses 
Research Question 
Is there a significant difference between recency of graduation, physician 
specialty, or opioid lmowledge in physicians' decisions to prescribe opioids or alternative 
treatments in chronic pain management? 
The present study was conducted to evaluate two primary hypotheses: 
Hypothesis 1: It was hypothesized that there would be a significant and negative 
association between years since graduation and opioid knowledge. 
Hypothesis 2: It was hypothesized there would be a significant and negative 
correlation between year since graduation and number of non-opioid alternative 
treatments used to treat the chronic pain of the patient presenting in the vignette. 
Rationale for primary hypotheses. The current opioid epidemic has increased 
public, political, and professional efforts to identify and implement strategies to address 
this crisis. This increased focus has led to a number of major shifts impacting prescription 
policies and medical training. Given the more recent implementation of these policies, 
particularly those addressing medical education, it is possible that more recent medical 
school graduates may have both higher levels of knowledge about opioids and addiction 
and greater familiarity with alternative non-opioid pain management strategies (NIH, 
2010; Abbott et al., 2011; Neufield et al., 2012; Satterfield et al., 2012). 
Exploratory Analysis: To examine the relationship between physician specialty, 
among other demographic variables, and opioid knowledge and number of non-opioid 
pain treatment recommendations for the patient in the vignette. 
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Chapter 3: Methodology 
Design 
This study employed a correlational design to explore the relationship between 




This study utilized a convenience sample in which potential participants received 
a Survey Monkey link through email and social media (e.g. Facebook, Reddit). Affiliates 
of the osteopathic medicine program at the Philadelphia College of Osteopathic Medicine 
were contacted with the Survey information through email. 
Inclusion criteria. Eligible participants were those that have a doctoral degree in 
medicine (MD) or in osteopathic medicine (DO), who speak English fluently, are 
between the ages of 20 and 70, and are licensed. All eligible participants were required to 
be practicing physicians in one of the following specialties: family medicine, internal 
medicine, pain management, geriatric medicine, and physical medicine and rehabilitation. 
Exclusion criteria. There were no exclusion criteria once inclusion criteria was 
met. Physicians who were no longer in practice or who worked solely in a teaching or 
research capacity were excluded, as well as those who did not speak English fluently or 
who fell outside of the indicated age range. Potential participants were screened at the 
start of the survey following the solicitation statement. 
Recruitment. With a medium effect size of .5 and an alpha of .05, it was 
estimated that a sample size of approximately 85 participants would be required to obtain 
a recommended statistical power of .80 for the primary hypothesis. This process began 
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with interdisciplinary consultations with experts experienced in medicine and research to 
determine the most effective approaches for contacting physicians. Attempts were made 
to recruit participants through medical organizations (e.g. American Medical Association 
and American Osteopathic Association), but the majority of participants were contacted 
through university affiliates and private social media groups. Once engaged with methods 
of contact, the survey in its entirety, including: informed consent, a demographic 
questionnaire, chronic pain vignette with potential treatment selections, and opioid 
knowledge survey were disseminated. Upon completion of the survey, participants were 
provided with instructions to enter into a raffle for a VISA gift card. 
Measures 
Screening. Those who entered into the survey were asked to indicate their current 
work status (i.e. currently practicing physicians or not practicing physicians), and 
specialty, whether or not they speak English fluently, and if they are between the ages of 
20 and 70. This was done to determine eligibility for participation. 
Chronic pain vignette. After participants completed the brief screener and were 
determined to be eligible for inclusion, they were presented with a brief vignette 
depicting a patient with chronic pain (see Appendix A). Participants were instructed to 
note the treatment recommendation that they would provide to the patient, based on a list 
of medical and mental health treatments for chronic pain. Recommendation selections 
included: cognitive behavioral therapy, opioid therapy, benzodiazepines, acupuncture, 
chiropractic treatment, mindfulness/meditation, physical therapy, nutritional counseling, 
biofeedback, and non-steroidal anti-inflammatory drugs. Participants were able to 
endorse as many treatments options as they deemed appropriate. This vignette was 
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developed for the purposes of this study. Treatments were selected, based on a review of 
alternatives to opioids discussed in chronic pain treatment literature. 
Opioid knowledge survey. Participants were asked to complete a brief survey 
inquiring about opioid use knowledge (see Appendix B). This survey was developed 
specifically for this study. This measure consists of 26 questions with a mixture of 
objective and multiple choice questions. Items were adapted using guidelines and 
statistics from the CDC (2012, 2016b ), American Society of Addiction Medicine 
(Kampman & Jarvis, 2015), and SAMHSA (2016s). This survey was reviewed with 
experts to determine validity of the items within the scale. 
Items on this measure focus specifically on assessing knowledge ofrisks 
associated with opioid use (e.g. which of the following are risk factors for the 
development of an opioid use disorder or opioid overdose? Indicate all that apply), 
knowledge of recommended prescribing practices (e.g. relief of acute chronic pain can 
often occur with a prescription for ___ days or less and), and awareness of 
alternatives to opioid prescriptions (e.g. Which of the following types of antidepressants 
have been shown to have an analgesic effect for neuropathic pain and fibromyalgia?) 
Demographic questionnaire. Last, participants were provided with a 
demographic questionnaire inquiring about age, sex, race, graduation year, specialty, 
years in practice, and whether or not they have had experience in treating: chronic pain, 
opioid use disorders, diabetes, and other substance use disorders (i.e. yes/no). See 
Appendix C. 
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Procedure 
The author of the study sought approval for this research study from the Chair and 
co-Chair prior to its submission to the Institutional Review Board (IRB) for permission to 
conduct this study. All data analyses were conducted using SPSS software. Potential 
participants were contacted through email and social media, through which they were 
informed of the purpose of the study, their eligibility to participate, and their opportunity 
to be entered into a raffle for a chance to win $100 Visa gift card upon completion of the 
study. Individuals who chose to participate were subsequently asked to follow a link 
through Survey Monkey where they were once again informed of the purpose of the 
study and eligibility for participation. Once informed consent was obtained, individuals 
who continued were provided with all measures (i.e. the screener, vignette, opioid 
knowledge survey, and demographic questionnaire). Upon completion of the study 
measures, participants were thanked for their time and informed that they should email 
erinho@pcom.edu to enter their names for the aforementioned gift card raffle. 
After the data was collected, it was transposed to Excel, then SPSS file, and 
analyzed, 
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Chapter 4: Results 
Analysis of Power 
A power analysis was conducted to determine the minimum number of 
participants necessary to examine the primary hypothesis. Estimating a medium effect 
size, and an alpha of .05, a sample size of 85 was determined necessary to provide 
statistical power of. 80 to examine the primary hypotheses, that ( 1) there will be a 
significant and negative association between years since graduation and opioid 
lmowledge, and (2) that there will be a significant and negative association between years 
since graduation and number of alternative treatments used to treat the chronic pain of the 
patient presenting in the vignette. 
Participant Sample and Descriptive Statistics 
Responded to survey (N = 93) 
Excluded (N = 30) 
+ Did not consent (n = 1) 
+ Not a licenced physician (n = 20) 
+ Not between age 20 and 70 (n = 1) 
+ Not in one of the medical specialty areas (n = 8) 
Moved on to vignette (n = 63) I 
+ Completed remainder of survey items 
and included in analyses (N = 49) 
Figure 1. Consort Diagram of Participant Inclusion and Exclusion 
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As seen in Figure 1, a total of93 individuals entered into the survey. A total of30 
individuals were excluded from the study for the following reasons: 1 person did not 
consent to participate, 1 did not fall within the specified age range for inclusion, 8 did not 
meet the requirements for inclusion based on specialty, and 20 were not licensed 
physicians. Of the 63 participants who met the inclusion criteria and consented to 
participate, 14 responded to the vignette, but did not complete the remaining survey items 
(i.e. opioid knowledge survey and demographic questionnaire). A total of 49 participants 
were included in the final analyses. 
Table 1 
Demographic Variables Descriptive Statistics (N=49) 
Variable MCSD) N(%) 
Age 41.84 (11.6) 
Biological Sex 
Male 28 (57.1) 
Female 21 (42.9) 
Race/Ethnicity 
Black 2 (4.1) 
White 33 (67.3) 
Hispanic/Latino 1 (2.0) 
Asian American/Pacific Islander 10 (20.4) 
Other 3 (6.1) 
Years Since Graduating Medical School 14.33 (12.6) 
Years Practicing Medicine 12.00 (10.8) 
Medical Specialty 
Family 38 (77.6) 
Internal 9 (18.4) 
Pain management 1 (2.0) 
Geriatrics 1 (2.0) 
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Descriptive statistics were calculated for the entire sample on the following 
variables: age, sex, race, graduation year, specialty, years in practice, chronic pain 
treatment selections, and prior experience working with opioid use disorder, diabetes, 
chronic pain, fibromyalgia, alcohol use disorder, and other substance use disorders. 
44 
The mean age of the sample was 41.84, with 57.1 % of the sample identifying as 
male and 42.9% identifying as female. The majority of participants identified themselves 
as White (67.3%); 4.1 % identified as Black; 2% identified as Hispanic/Latinx; 20.4% 
identified as Asian American/Pacific Islander, and 6.1 % identified as Other. The average 
amount of years since medical school graduation and years in practice was 14.33 and 12, 
respectively. The range of years since medical school graduation was less than one year 
to 43 years. Approximately one half of the sample had graduated more than 11 years ago. 
Family medicine was the most common physician specialty endorsed (77.6%), followed 
by internal medicine (18.4%). Pain management and geriatric medicine were each 
endorsed by 1 participant (2%, each). 
Importantly, only two of the physicians in this sample endorsed opioid treatment for 
the patient in the vignette. Characteristics of these two participants were examined and no 
unique differences were found. The most common treatment selections were NSAIDs and 
physical therapy, each of which had 44 endorsements, followed by acupuncture and 
mindfulness based stress reduction (MBSR)/meditation, with 26 and 22 endorsements, 
respectively. These endorsements can be viewed within Figure 2. A total of 186 treatment 
were endorsed among the entire sample, indicating that many physicians selected several 
treatment modalities. 
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Figure 2. Chronic Pain Vignette Treatment Selections 
Hypotheses 1 and 2 
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I I 
The two primary hypotheses were analyzed using bivariate correlations to identify 
associations between the independent variable, years since medical school graduation, 
and the dependent variables, opioid knowledge score (Hl) and total number of non-
opioid pain management strategies endorsed for the vignette (H2). Correlations were 
also conducted to examine the association between the demographic variables and the 
dependent variables to determine which, if any, should be included in a regression model. 
Ultimately, however, a linear regression was not completed because bivariate correlations 
indicated no statistically significant relationship between years since graduation and 
opioid knowledge r = .027,p = n.s. or years since graduation and number of non-opioid 
treatments recommended r = -.186,p = n.s. (see Table 2). 
PHYSICIANS' USE OF PAIN MANAGEMENT STRATEGIES 
Table 2 














* p < .05, two-tailed 








Years w/ Years 












In order to evaluate between group differences in the independent variables (i.e. 
race, biological sex, and physician specialty) on the dependent variables (i.e. opioid 
knowledge and non-opioid treatment selections) means and percentages were calculated, 
using a one way analysis of variance (ANOVA). An ANOVA has three basic 
assumptions that must be met: the assumption of independence, assumption of normality, 
and assumption of homogeneity of variance. By design, each sample (i.e. race, specialty, 
and biological sex) was independent from others. To ensure normality and equal or 
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similar variance in race/ethnicity and physician specialty, these categories were 
combined. Specifically, White participants were compared with all other racial/ethnic 
identifications, and family physicians were compared with all other physician specialties. 
No statistically significant differences in opioid knowledge were found between males 
and females F(l, 49) = .00, p = .98, individuals identifying as White or a member of 
other racial groups F(l, 49) = .60,p = .44, or family physicians and other physicians F(l, 
49) = 1.27,p = .27 (see Table 3). Similarly, no significant differences in non-opioid 
treatment recommendations were found between males and females F(l, 49) = .18,p = 
.67, White participants and other racial groups F(l, 49) = 2.93,p = .09, or family 
physicians and other specialties F(l, 49) = .35,p = .56 (see Table 4). 
Table 3 
Opioid Knowledge Score by Participant Characteristics 
N M SD F Sig. 
Biological Sex 
Male 28 15.39 1.95 
Female 21 15.38 1.91 .00 .98 
Race/Ethnicity 
White 34 15.53 1.85 
Other 15 15.07 2.09 .60 .44 
Specialty 
Family 38 15.55 1.98 
Other 11 14.82 1.60 1.27 .27 
Note (N =49) 
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Table 4 
Number of Non-opioid Treatments Endorsed by Participant Characteristics (N =49) 
N M SD F Sig. 
Biological Sex 
Male 28 3.86 2.01 
Female 21 3.62 1.80 .18 .67 
Race/Ethnicitv 
White 34 4.06 1.87 
Other 15 3.07 1.87 2.92 .09 
Specialty 
Familv 38 3.84 1.75 
Other 11 3.45 2.46 .35 .56 
Note (N = 49) 
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Chapter 5: Discussion 
Implications 
Findings from this study can be used to inform medical and mental health 
professionals about barriers in reducing the negative impact of the current opioid 
epidemic, especially given the absence of research on physician characteristics as they 
relate to chronic pain treatment strategies or substance use disorders. Although study 
findings did not support the hypotheses and no specific relationships were fotmd between 
physician characteristics and treatment selections or opioid knowledge, this study can act 
as a framework for future research. Physician attitudes and knowledge are known 
potential barriers to appropriate patient care for those that experience chronic pain (Chen 
et al., 2007; Hirsh et al., 2014); this is relevant in the opioid crisis discussion because 
chronic pain can be a precursor to substance use disorders, some of which escalate to the 
use of illicit substances (Muhuri et al., 2013). As such, it seems plausible that future 
research may find other characteristics that contribute to treatment of both chronic pain 
and substance use alike. 
Overall, findings from this study could add to a growing body of research aimed 
towards a better understanding of the factors that contribute to the prevention of opioid 
addiction while highlighting gaps within the literature. Despite the call to action from 
medical and mental health organizations to reduce prescription opioid use (USDHHS, 
2016), pain and substance use management continue to present difficulties for 
professionals exacerbated by limited standardization in medical education on addiction. 
Evaluating associations between physician characteristics, opioid and non-opioid 
treatments for chronic pain management, and opioid knowledge, can provide information 
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about important areas to address in addiction education. Furthermore, continued research 
and education can help facilitate the reduction and the prevention of reliance on opioid 
prescriptions for patients and professionals alike. 
Limitations 
The true impact of these results is hindered by some important limitations. As 
with all self-report measures, there is the concern that respondents may have attempted to 
present themselves in a more favorable light by providing treatment recommendations 
that may not be totally congruent with the recommendations they would provide to actual 
patients. The researcher attempted to control for this limitation by providing the opioid 
knowledge survey and demographics survey following the vignette to avoid patients 
being primed to be mindful of their opioid referrals. An additional challenge with self-
report surveys, such as those used in this study, is that respondents may not be the most 
accurate historians of their prescribing practices. 
Another limitation of the study may be associated with psychometric properties of 
the vignette and assessments. Specifically, all measures were made for this study by the 
researcher; although best efforts were made to produce reliable instruments, they were 
not formally assessed for validity and reliability, which may have influenced findings. 
For example, items on the opioid knowledge survey may have been related to opioids, but 
the relevance of items (e.g. statistics) may not be entirely pertinent to treatment. 
Additionally, responses on the vignette may have been limited due to the close-ended 
nature of the prompt. 
This research may also have limited external validity. The limited sample size 
precludes generalizability of the findings to all physicians (e.g. those at other institutions, 
PHYSICIANS' USE OF PAIN MANAGEMENT STRATEGIES 51 
specialties, or geographical areas). Concerns about generalizability are largely associated 
with recruitment. For example, it is possible that those with a vested interest in the topic 
of the study may have been more likely to respond than those that are not interested in 
chronic pain treatment. Similarly, certain clinicians may find themselves working with 
patients that experience chronic pain or substance use disorders more frequently than 
other clinicians, and this could have influenced the responses provided. Last, teaching 
hospitals and affiliates of the college through which this study was being conducted are 
believed to have comprised a large portion of this sample. Those affiliated with academia 
or teaching in clinical settings may respond differently from those that are not. 
Finally, the recency of new guidelines and measures associated with improving 
chronic pain and substance use disorder treatment and generating safer pain management 
and opioid prescribing practices may account for the findings ofthis study because it 
takes time for research to be translated to practice. As such, timing may be a limitation, 
and a replication of this study in the future has the potential to yield more significant 
findings related to time since medical training. 
Future directions 
Future research on physician characteristics would benefit from collecting a larger 
sample that is more representative of the physician population in order to address more 
comprehensively those physician characteristics that play a role in opioid knowledge and 
use of alternative treatments. Some research suggests that there continue to be differences 
between physician degree programs that could influence treatment (Peters, Clark-
Chiarelli, & Block, 1999; Johnston & Kurtz, 2002; Carey, Motyka, Garrett, & Keller, 
2003), but information on this is limited. Studying other medical professionals with 
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prescribing privileges, such as nurse practitioners, would be an interesting avenue for 
exploring opioid prescribing practices as well. A better understanding of practitioner 
characteristics may also be beneficial in reducing racial disparities in opioid 
prescriptions. In evaluating characteristics, future researchers may want to consider 
looking more deeply into prescriber and patient characteristics beyond those discussed in 
this study, including the ways that these characteristics intersect (e.g. SES, age, 
education, race, gender, geographical region etc.). In 2017, NIDA published a rank order 
list of opioid deaths per 100,000. The greatest number occurred in West Virginia ( 49.6), 
and the least number of opioid deaths occurred in Nebraska (3.1). Pennsylvania, where 
this study was conducted, was 14th on this list (NIDA, 2019). Evaluating physician and 
patient characteristics associated with these rankings could provide further insight into 
opioid prescribing, addiction medicine, and pain management. 
Additionally, research may find it beneficial to include a greater amount of 
alternative treatments to create opportunities for variance. Such inclusions might be 
osteopathic manipulation therapy, which was suggested by numerous participants in the 
present study, or cannabis based interventions, which became newly available during the 
course of this study (Commonwealth of Pennsylvania, 2019). Although not all of the 
alternative pain management strategies included as potential treatments for the patient in 
the vignette have equivalent support, they do represent alternatives to opioid based pain 
management, which is currently contraindicated in many chronic pain conditions. 
Therefore, endorsement of more alternative options may be indicative of openness or 
willingness to consider non-opioid intervention options. Furthermore, selection of 
alternative pain strategies may reflect differences between training, openness to new 
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treatments, or even the perceived importance of multi-modal or multi-disciplinary 
approaches, all of which may be worth investigating in future studies. 
Last, future research on the relationship between chronic pain or substance use 
disorder knowledge and associated mental health conditions may be beneficial in 
highlighting areas in medical training in which mental health education may be 
insufficient, or what brief therapeutic knowledge or intervention training from which 
physicians could benefit. 
53 
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Appendix A 
Patient Vignette 
A patient arrives at your facility for medical treatment. The patient presents with 
significant chronic pain as a result of a car accident that occurred approximately 6 months 
ago. The patient reports experiencing nearly constant low back pain on a daily basis. The 
patient states that their pain feels severe and they rate it as ranging from 7-8 on a 10-point 
scale. Please select which of the following treatment( s) you might suggest from the list 
below to help them to manage their pain. 
Potential treatments 
o Mindfulness Based Stress Reduction/Meditation 
o Opioid-Based Medications 
o Benzodiazepines 
o Acupuncture 
o Chiropractic Treatment 
o Biofeedback 
o Physical Therapy 
o Cognitive Behavioral Therapy 
o Nonsteroidal anti-inflammatory drugs 
o Nutritional Counseling 
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AppendixB 
Opioid Knowledge Survey 
1. Opioids can be prescribed for the management of chronic pain when the benefits 
to pain and outweigh the risks. 
A. Cost 
B. Function 
C. Ease of Access 
D. Likelihood of patient compliance 
2. Which of the following types of anti-depressants have been shown to have an 
analgesic effect for neuropathic pain and fibromyalgia? 
A. Serotonin-norepinephrine reuptake inhibitors 
B. Tricyclics 
C. Selective serotonin reuptake inhibitor 
D. AandB 
E. All of the above 
3. ______ is a therapeutic approach shown to be effective for chronic pain 
management. 
A. Stress Inoculation Training 
B. Transactional Analysis 
C. Dialectical Behavior Therapy 
D. Cognitive Behavior Therapy 
4. According to current research, long term opioid use is associated with a(n) 
____ impact on quality oflife and a(n) impact on long term pain 
relief. 
A. Unknown; Positive 
B. Unknown; Unknown 
C. Negative; Positive 
D. Positive; Negative 
5. Opioids should be considered first-line or routine treatment for the management 
of chronic pain. 
A. True 
B. False 
6. When prescribing opioids for the management of chronic pain, physicians may 
begin by prescribing extended release/long lasting opioids 
A. True 
B. False 
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D. Never prescribe opioids for acute pain management 
9. After a patient begins an opioid regimen, clinicians should review the benefits and 





10. Circle all of the following that clinicians should consider for patients prescribed 
opioids who are at an increased risk for opioid abuse or misuse: 
A. Offering Naloxone 
B. Re-evaluating patients more frequently 
C. Referral to pain specialists 
D. Referral to behavioral health specialists 
11. Which of the following are risk factors for the development of an opioid use 
disorder or opioid overdose? Indicate all that apply. 
A. History of Overdose 
B. History of Substance Use Disorder 
C. Currently taking a dose of greater than 50 MME/day 
D. Concurrent Use ofbenzodiazepines and opioids 
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12. Which of the following measures can be used as brief screening instruments for 
substance abuse? Indicate all that apply. 
A. CAGE/AUDITIDAST 
B. P AI/MMPI/MCMI 
C. SCID/PHQ-9/PHQ-SADS 
D. BDI/GAD-7/SAFE-T 
13. The following risk stratification tools show sufficient accuracy for classification 
of patients at low or high risk for opioid abuse or misuse: Opioid Risk Tool, 
Screener and Opioid Assessment for Patients with Pain Version 1, SOAPP-R, and 
Brief Risk Interview. 
A. True 
B. False 
14. Clinicians should use urine drug testing prior to starting opioid treatment and 
consider continuing urine drug testing for prescribed medications, other controlled 





15. From 1999-2014 there were approximately _____ deaths related to 





16. In 2014 approximately _____ Americans over the age of 12 had a 
substance use disorder 
A. 9 million 
B. 21.S million 
C. 17.4 million 
D. 29.3 million 
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17. In 2015 approximately _____ Americans 18 and older received treatment 
for a substance use disorder 
A. 15.5 million 
B. 3.5 million 
C. 7.5 million 
D. 11.5 million 
18. Since 2003, there have been more overdoses attributed to opioid-based pain 
relievers than heroin and cocaine combined. (CDC, 2012) 
A. True 
B. False 
19. Which of the following medications are NOT clinically indicated for the 





20. Medication based opioid withdrawal management on its own is not a treatment 




21. Federal law indicates that initial doses of methadone for those with opioid use or 





22. Patients who discontinue opioid agonists and resume opioid use are at an 
increased risk of overdose death. 
A. True 
B. False 
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23. Which of the following is a minimum expectation of psychosocial treatment for 
opioid use disorders? 
A. Blood work 
B. Psychodiagnostic assessment 
C. Referrals to community resources 
D. Opioid Education 
24. Psychosocial treatment is generally recommended for those who are receiving 
opioid agonist treatment 
A. True 
B. False 
25. Patients and family members/significant others should be trained in the use of 
naloxone in overdose 
A. True 
B. False 
26. Patients on naltrexone with moderate to severe pain should be treated with 
on a short term basis. 
----




*Note bolded responses indicate correct responses 
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Years in Practice: 
Select Yes or No if you have worked with individuals diagnosed with the following 
conditions: 




-Alcohol use disorder 
-Another substance use disorder 
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